Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy

Author:

Claps Francesco12ORCID,van de Kamp Maaike W.1,Mayr Roman3,Bostrom Peter J.45,Shariat Shahrokh F.6789,Hippe Katrin10,Bertz Simone11,Neuzillet Yann11213,Sanders Joyce12,Otto Wolfgang3,van der Heijden Michiel S.14,Jewett Michael A.S.4ORCID,Stöhr Robert11,Zlotta Alexandre R.4,Trombetta Carlo2,Eckstein Markus11,Mertens Laura S.1ORCID,Burger Maximilian3,Soorojebally Yanish13,Wullich Bernd15,Bartoletti Riccardo16,Radvanyi François13,Pavan Nicola2ORCID,Sirab Nanour13,Mir M. Carmen17ORCID,Pouessel Damien1318,van der Kwast Theo H.19,Hartmann Arndt11,Lotan Yair6ORCID,Bussani Rossana20,Allory Yves1321,van Rhijn Bas W.G.134

Affiliation:

1. Department of Surgical Oncology (Urology) Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

2. Urological Clinic, Department of Medicine, Surgery and Health Sciences University of Trieste Trieste Italy

3. Department of Urology, Caritas St Josef Medical Center University of Regensburg Regensburg Germany

4. Department of Surgery (Urology) and Surgical Oncology University Health Network, Princess Margaret Cancer Center University of Toronto Toronto ON Canada

5. Department of Urology Turku University Hospital and University of Turku Turku Finland

6. Department of Urology University of Texas Southwestern Medical center Dallas TX USA

7. Department of Urology Weill Cornell Medical College New York NY USA

8. Department of Urology, Comprehensive Cancer Center Medical University of Vienna Vienna Austria

9. Department of Urology Second Faculty of Medicine, Charles University Prague Czech Republic

10. Department of Pathology University Medical Center – Regensburg Regensburg Germany

11. Institute of Pathology, University Hospital Erlangen Friedrich‐Alexander‐University Erlangen/Nurnberg Erlangen Germany

12. Core Facility Molecular Pathology & Biobank Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

13. Institut Curie, CNRS, UMR144, Molecular Oncology Team PSL Research University Paris France

14. Department of Medical Oncology Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

15. Department of Urology & Pediatric Urology University Hospital Erlangen, Friedrich‐Alexander‐University Erlangen/Nurnberg Erlangen Germany

16. Unit of Urology Department of Translational Research and New Technologies University of Pisa Pisa Italy

17. Department of Urology Fundacion Instituto Valenciano Oncologia Valencia Spain

18. Department of Medical Oncology Claudius Regaud Institute, Toulouse University Cancer Center (IUCT) Oncopole Toulouse France

19. Department of Pathology University Health Network, Princess Margaret Cancer Center University of Toronto Toronto ON Canada

20. Department of Pathology University of Trieste Trieste Italy

21. Department of Pathology Institut Curie Paris France

Abstract

ObjectivesTo evaluate variant histologies (VHs) for disease‐specific survival (DSS) in patients with invasive urothelial bladder cancer (BCa) undergoing radical cystectomy (RC).Materials and MethodsWe analysed a multi‐institutional cohort of 1082 patients treated with upfront RC for cT1‐4aN0M0 urothelial BCa at eight centres. Univariable and multivariable Cox’ regression analyses were used to assess the effect of different VHs on DSS in overall cohort and three stage‐based analyses. The stages were defined as ‘organ‐confined’ (≤pT2N0), ‘locally advanced’ (pT3‐4N0) and ‘node‐positive’ (pTanyN1‐3).ResultsOverall, 784 patients (72.5%) had pure urothelial carcinoma (UC), while the remaining 298 (27.5%) harboured a VH. Squamous differentiation was the most common VH, observed in 166 patients (15.3%), followed by micropapillary (40 patients [3.7%]), sarcomatoid (29 patients [2.7%]), glandular (18 patients [1.7%]), lymphoepithelioma‐like (14 patients [1.3%]), small‐cell (13 patients [1.2%]), clear‐cell (eight patients [0.7%]), nested (seven patients [0.6%]) and plasmacytoid VH (three patients [0.3%]). The median follow‐up was 2.3 years. Overall, 534 (49.4%) disease‐related deaths occurred. In uni‐ and multivariable analyses, plasmacytoid and small‐cell VHs were associated with worse DSS in the overall cohort (both P = 0.04). In univariable analyses, sarcomatoid VH was significantly associated with worse DSS, while lymphoepithelioma‐like VH had favourable DSS compared to pure UC. Clear‐cell (P = 0.015) and small‐cell (P = 0.011) VH were associated with worse DSS in the organ‐confined and node‐positive cohorts, respectively.ConclusionsMore than 25% of patients harboured a VH at time of RC. Compared to pure UC, clear‐cell, plasmacytoid, small‐cell and sarcomatoid VHs were associated with worse DSS, while lymphoepithelioma‐like VH was characterized by a DSS benefit. Accurate pathological diagnosis of VHs may ensure tailored counselling to identify patients who require more intensive management.

Publisher

Wiley

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3